Recognition for Transformative Healthcare Impact
Xenco Medical has been recognised by Time Magazine as one of the TIME100 Most Influential Companies in the World and the recipient of the 2026 TIME100 Impact Award in Health. This accolade highlights the company’s significant influence in the global healthcare sector.
TIME Magazine’s TIME100 Most Influential Companies list includes organisations that are making extraordinary impacts worldwide. According to Time, being included in this list is one of the highest honors a company can achieve. Xenco Medical’s selection as the sole recipient of the TIME100 Impact Award in Health in 2026 underscores its transformative contribution to healthcare innovation.
The TIME100 Impact Awards are prestigious, with only five recipients each year across various categories. Xenco Medical’s recognition in the health category underscores its transformative impact in the field. The company has distinguished itself through its groundbreaking technologies, such as biomimetic implants and regenerative biomaterials.
Jason Haider, Founder and CEO of Xenco Medical, expressed gratitude for the award, stating, “We are immensely honored and profoundly humbled to be named the 2026 Winner of the TIME100 Impact in Health Award and a TIME100 Most Influential Company in the World.” His statement reflects the company’s commitment to transforming healthcare through innovation.
Innovative Technologies and Global Reach
Xenco Medical is a leader in life sciences, known for its biomimetic implants, regenerative biomaterials, and AI-enabled technologies. Its TrabeculeX Continuum technology synergistically combines regenerative biomaterials with AI for post-surgical rehabilitation, marking a breakthrough in surgical care. The platform allows surgeons to remotely monitor pain scores and rehabilitation adherence, inspired by the principles of mechanotransduction.
The company’s single-use surgical implant systems have improved healthcare facility efficiency by reducing surgical turnover times and eliminating the reprocessing of instruments. This logistics-driven approach is redefining value-based healthcare. As a result, Xenco Medical has positioned itself as a standard-bearer for innovation in the medical technology field.
Xenco Medical was also named the 2025 Medical Device/Diagnostics Company of the Year at the Trailblazer Awards in New York City. Fast Company Magazine recognised it as one of the World’s Most Innovative Companies for the second time in 2025, further highlighting its leadership in the medical technology sector.
Further recognition came when Xenco Medical won the World Economic Forum’s 2025 Award for Excellence in Governance and Leadership for Global Challenges. These accolades emphasise its commitment to innovation and leadership in healthcare, solidifying its reputation as a transformative force in the industry.
The full list of TIME100 Most Influential Companies, including Xenco Medical, is available on newsstands worldwide as of 1st May 2026. This list celebrates companies making extraordinary impacts around the world.
